Waverley Pharma Inc (WAVE) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.024x

Based on the latest financial reports, Waverley Pharma Inc (WAVE) has a cash flow conversion efficiency ratio of 0.024x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-65.14K ≈ $-47.12K USD) by net assets (CA$-2.73 Million ≈ $-1.97 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. View current stock price of Waverley Pharma Inc for real-time trading data and today's change.

Waverley Pharma Inc - Cash Flow Conversion Efficiency Trend (2015–2025)

This chart illustrates how Waverley Pharma Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Also see market value of Waverley Pharma Inc for the company's overall valuation and market capitalisation.

Waverley Pharma Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Waverley Pharma Inc ranked by their cash flow conversion efficiency. Also see Waverley Pharma Inc assets under control for a full breakdown of the balance sheet.

Company	Cash Flow Conversion Efficiency
African Dawn Capital Ltd JSE:ADW	0.088x
ArcelorMittal SA LSE:0RP9	0.077x
Nulegacy Gold Corporation V:NUG	-0.070x
Hitech & Development Wireless Sweden Holding AB (publ) ST:HDW-B	-2.203x
Discovery Harbour Resources Corp V:DHR	-0.057x
PT Century Textile Industry Tbk JK:CNTX	0.077x
FINCANNA CAPITAL CORP. F:4AL0	N/A
CHINA HEALTH GRP HD-10 F:VNL1	N/A

Annual Cash Flow Conversion Efficiency for Waverley Pharma Inc (2015–2025)

The table below shows the annual cash flow conversion efficiency of Waverley Pharma Inc from 2015 to 2025. Review WAVE financial flexibility score to assess the company's free cash flow relative to its total liabilities.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CA$-2.57 Million ≈ $-1.86 Million	CA$-611.03K ≈ $-442.01K	0.238x	+17.72%
2024-12-31	CA$-2.03 Million ≈ $-1.47 Million	CA$-410.19K ≈ $-296.73K	0.202x	-77.52%
2023-12-31	CA$-1.14 Million ≈ $-822.30K	CA$-1.02 Million ≈ $-738.66K	0.898x	+513.44%
2022-12-31	CA$1.09 Million ≈ $789.27K	CA$-237.06K ≈ $-171.49K	-0.217x	+51.33%
2021-12-31	CA$1.79 Million ≈ $1.29 Million	CA$-798.78K ≈ $-577.82K	-0.446x	-152.15%
2020-12-31	CA$2.04 Million ≈ $1.48 Million	CA$-361.70K ≈ $-261.65K	-0.177x	+64.34%
2019-12-31	CA$2.85 Million ≈ $2.06 Million	CA$-1.41 Million ≈ $-1.02 Million	-0.497x	-35.82%
2018-12-31	CA$3.97 Million ≈ $2.87 Million	CA$-1.45 Million ≈ $-1.05 Million	-0.366x	-1600.85%
2017-12-31	CA$5.06 Million ≈ $3.66 Million	CA$-108.69K ≈ $-78.62K	-0.021x	-100.23%
2016-12-31	CA$-11.62K ≈ $-8.41K	CA$-108.69K ≈ $-78.62K	9.350x	-9.27%
2015-12-31	CA$-10.55K ≈ $-7.63K	CA$-108.69K ≈ $-78.62K	10.306x	--

About Waverley Pharma Inc

V:WAVE Canada Biotechnology

Market Cap

$585.94K

CA$810.00K CAD

Market Cap Rank

#30933 Global

#1636 in Canada

Share Price

CA$0.02

Change (1 day)

+0.00%

52-Week Range

CA$0.01 - CA$0.03

All Time High

CA$0.60